Related Experiment Video
Updated: Feb 25, 2026

08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
7.0K
Neutropenic sepsis.
1London.
Summary
This article reviews neutropenic sepsis, a serious chemotherapy complication. It covers prevention, identification, and treatment strategies for better patient outcomes.
Area of Science:
- Oncology
- Hematology
- Infectious Diseases
Background:
- Neutropenic sepsis is a critical complication in cancer patients undergoing chemotherapy.
- Early recognition and management are vital to reduce mortality.
Purpose of the Study:
- To provide a comprehensive overview of neutropenic sepsis.
- To outline current best practices for prevention, identification, and treatment.
Main Methods:
- Literature review on neutropenic sepsis management.
- Synthesis of evidence-based guidelines and clinical recommendations.
Main Results:
- Neutropenic sepsis requires prompt diagnosis and aggressive treatment.
- Prophylactic measures and vigilant monitoring are key to prevention.
Conclusions:
- Effective management of neutropenic sepsis improves patient survival rates.
- Multidisciplinary collaboration is essential for optimal patient care.
Related Concept Videos
Acute Pyelonephritis I: Introduction
831
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
831
Acute Pyelonephritis II: Diagnostic Studies and Management
509
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
509
Pneumonia II: Pathophysiology
3.4K
The pathophysiology of pneumonia involves the following steps:
3.4K
Pneumonia IV: Management
868
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
868
Pneumonia III: Complications and Assessment
966
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
966
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
6.0K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
6.0K

